As You Read Here Now, The More You Enjoy Coming Back


Acne Cure Solutions...

I am not sure if any BTB have acne problem. For me, i did last 2 years due to hormone scarring change. I did try many products and salon facial. But, nothing really works on me. I was so desperate because cyst PS was coming and wedding in 3 months. Hence, my manager recommended me go to dermatologist home remedies. Hence i went to Boston University Dermatology deforestation overpopulation and gave a try free diet ebook for adults that work review. I didn't take any oral prescription because my body cannot take it. (i have weak body...sad.gif ...cannot take too much antibiotic). Hence, they prescribe me the cream/gel to apply. After 6 months, my skin totally changed plus wedding is over..no more stress....I can see no more acne and scar fade away....once a while still pop one or 2...but very few. For a severe acne problem person scar treatment problem vulgaris aid product, i would recommend this cream.....my coworkers has been suing this cream for 4 yrs....her skin is really good..biggrin.gif
Here is the cream and gel that i am using:
(You may ask your dermatologist about these 2 items because they need prescriptions)
DESCRIPTION: DIFFERIN® Gel, containing adapalene, is used for the topical treatment of acne vulgaris. Each gram of DIFFERIN® Gel contains adapalene 0.1% (1 mg) in a vehicle consisting of carbomer 940, poloxamer 182, edetate disodium, methylparaben, sodium carbomer 940, edentate disodium, methylparaben poloxamer 182, propylene glycol, purified water and sodium hydroxide. May contain hydrochloric acid to adjust pH Acne cure solutions....
The chemical name of adapalene is 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid. Adapalene is a white to off-white powder which is soluble in tetrahydrofuran, sparingly soluble in ethanol, and practically insoluble in water. The molecular formula is C28H28O3 and molecular weight is 412.52. Adapalene is represented by the following structural formula:
CLINICAL PHARMACOLOGY: Adapalene is a chemically stable, retinoid-like compound. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization, and inflammatory processes all of which represent important features in the pathology of acne vulgaris.
Mechanistically, adapalene binds to specific retinoic acid nuclear receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.
PHARMACOKINETICS: Absorption of adapalene through human skin is low. Only trace amounts (<0.25 ng/mL) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials. Excretion appears to be primarily by the biliary route.
INDICATION AND USAGE: DIFFERIN® Gel is indicated for the topical treatment of acne vulgaris.
CONTRAINDICATIONS: DIFFERIN® Gel should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle gel.
WARNINGS: Use of DIFFERIN® Gel should be discontinued if hypersensitivity to any of the ingredients is noted. Patients with sunburn should be advised not to use the product until fully recovered.
PRECAUTIONS: General: If a reaction suggesting sensitivity or chemical irritation occurs, use of the medication should be discontinued. Exposure to sunlight, including sunlamps, should be minimized during the use of adapalene. Patients who normally experience high levels of sun exposure, and those with inherent sensitivity to sun, should be warned to exercise caution. Use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided. Weather extremes, such as wind or cold, also may be irritating to patients under treatment with adapalene.
Avoid contact with the eyes, lips, angles of the nose, and mucous membranes. The product should not be applied to cuts, abrasions, eczematous skin, or sunburned skin.
Certain cutaneous signs and symptoms such as erythema, dryness, scaling, burning or pruritus may be experienced during treatment. These are most likely to occur during the first two to four weeks and will usually lessen with continued use of the medication. Depending upon the severity of adverse events, patients should be instructed to reduce the frequency of application or discontinue use.
DRUG INTERACTIONS: As DIFFERIN® Gel has the potential to produce local irritation in some patients, concomitant use of other potentially irritating topical products (medicated or abrasive soaps and cleansers, soaps and cosmetics that have a strong drying effect, and products with high concentrations of alcohol, astringents, spices, or lime) should be approached with caution. Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with DIFFERIN® Gel. If these preparations have been used, it is advisable not to start therapy with DIFFERIN® Gel until the effects of such preparations in the skin have subsided.
CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: Carcinogenicity studies with adapalene have been conducted in mice at topical doses of 0.3, 0.9, and 2.6 mg/kg/day and in rats at oral doses of 0.15, 0.5, and 1.5 mg/kg/day, approximately 4-75 times the maximal daily human topical dose. In the oral study, positive linear trends were observed in the incidence of follicular cell adenomas and carcinomas in the thyroid glands of female rats, and in the incidence of benign and malignant pheochromocytomas in the adrenal medullas of male rats.
No photocarcinogenicity studies were conducted. Animal studies have shown an increased tumorigenic risk with the use of pharmacologically similar drugs (e.g., retinoids) when exposed to UV irradiation in the laboratory or to sunlight. Although the significance of these studies to human use is not clear, patients should be advised to avoid or minimize exposure to either sunlight or artificial UV irradiation sources.
In a series of in vivo and in vitro studies, adapalene did not exhibit mutagenic or genotoxic activities.
PREGNANCY: Teratogenic effects. Pregnancy category C. No teratogenic effects were seen in rats at oral doses of adapalene 0.15 to 5.0 mg/kg/day, up to 120 times the maximal daily human topical dose. Cutaneous route teratology studies conducted in rats and rabbits at doses of 0.6, 2.0, and 6.0 mg/kg/day, up to 150 times the maximal daily human topical dose exhibited no fetotoxicity and only minimal increases in supernumerary ribs in rats. There are no adequate and well-controlled studies in pregnant women. Adapalene should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when DIFFERIN® Gel is administered to a nursing woman.
PEDIATRIC USE: Safety and effectiveness in pediatric patients below the age of 12 have not been established.
ADVERSE REACTIONS: Some adverse effects such as erythema, scaling, dryness, pruritus, and burning will occur in 10-40% of patients. Pruritus or burning immediately after application also occurs in approximately 20% of patients. The following additional adverse experiences were reported in approximately 1% or less of patients: skin irritation, burning/stinging, erythema, sunburn, and acne flares. These are most commonly seen during the first month of therapy and decrease in frequency and severity thereafter. All adverse effects with use of DIFFERIN® Gel during clinical trials were reversible upon discontinuation of therapy.
OVERDOSAGE: DIFFERIN® Gel is intended for cutaneous use only. If the medication is applied excessively, no more rapid or better results will be obtained and marked redness, peeling, or discomfort may occur. The acute oral toxicity of DIFFERIN® Gel in mice and rats is greater than 10 mL/kg. Chronic ingestion of the drug may lead to the same side effects as those associated with excessive oral intake of Vitamin A.
DOSAGE AND ADMINISTRATION: DIFFERIN® Gel should be applied once a day to affected areas after washing in the evening before retiring. A thin film of the gel should be applied, avoiding eyes, lips, and mucous membranes.
During the early weeks of therapy, an apparent exacerbation of acne may occur. This is due to the action of the medication on previously unseen lesions and should not be considered a reason to discontinue therapy. Therapeutic results should be noticed after eight to twelve weeks of treatment.
Benzaclin is an acne treatment. Both its ingredients--the antibiotic clindamycin and the antibacterial agent benzoyl peroxide--attack the bacteria that help cause acne. Although Benzaclin is applied only to the skin, some of this medication could be absorbed into the bloodstream. Once in the system, it has been known to cause severe colitis. Symptoms include severe or bloody diarrhea and abdominal cramps.
Before applying BenzaClin® acne treatment , gently wash the affected skin and rinse with warm water. Pat the skin dry. Apply Benzaclin to the entire area, not just the pimples. Do not use Benzaclin more often than recommended by your doctor. Excessive use can make your skin dry or irritated.
BenzaClin® acne treatment should be applied twice a day, once in the morning and once in the evening, or as directed by your doctor. Before application, gently wash your face with a mild cleanser and warm water. Pat dry. Then, evenly spread a small amount of BenzaClin® acne treatment with your fingertips over the affected areas. Remember to follow your doctor's instructions. For any treatment to work effectively the dosing schedule should be followed. Be sure to contact your doctor right away if you are experiencing any uncomfortable effects from the product. Be patient, as all treatments take time to work. It may take two weeks or longer to see positive results from BenzaClin®. It will be worth the wait.
This medication can increase sensitivity to sunlight, wind and cold. Avoid prolonged exposure to the sun and sunlamps. Wear protective clothing and use an effective sunscreen. This medication should be used during pregnancy only if clearly needed.
If you miss a dose, use it as soon as remembered; do not use if it is almost time for the next dose, skip the missed dose and resume your usual dosing schedule. Do not "double-up" the dose to catch up.
Due to the possibility of irritation, it is advisable to begin treatment on a small area of skin. Exposure to the sun or to ultraviolet rays causes additional irritation.
Store at room temperature away from sunlight. Keep this and all medications out of the reach of children.
Applying BenzaClin® acne treatment excessively will not produce faster or better results. While an overdose of this medication is not likely to occur. If you suspect an overdose, call an emergency room or poison control left for advice.

&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;br/&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;gt;&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;a href="http://www.bing.com/videos/watch/video/hilarious-snow-maze-prank/20fxcwzs?fg=sharenoembed" target="_new"title="Hilarious Snow Maze Prank"&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;gt;Video: Hilarious Snow Maze Prank&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;/a&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;gt;

Donation Help Needed

It is aware that there is an old elderly woman needs some donation for her heart, diabetic and cancer disease expenses urgently. If you are generous enough now, you can easily bank in whatever you can donate to Hong Kong Shanghai Bank(HSBC) account number 302-005848-001 under the name Fauziah Binti Nasir.


Related Posts Plugin for WordPress, Blogger...